Background
==========

The Molecular Adsorbents Recirculating System (MARS) is a new promising artificial liver support therapy. The aim of this study was to assess the effectiveness of MARS to remove nitro oxide (NO) and cytokines in multiple organ dysfunction syndrome (MODS) with severe liver failure patients.

Methods
=======

One hundred and ten single MARS treatments were performed with a length of 6--24 hours on 39 various pathogenic MODS patients (27 male/12 female) (see Table [1](#T1){ref-type="table"}).

  Complication                                              *n*(%)
  --------------------------------------------------------- ------------
  Renal failure/hepatorenal syndrome                        28 (71.8%)
  Disseminated intravascular coagulation                    7 (17.9%)
  Brain edema/hepatoencephalopathy above grade II           28 (71.8%)
  Respiratory failure/acute respiratory distress syndrome   19 (48.7%)
  Cardiovascular dysfunction                                21 (53.8%)

  Parameter      Pretreatment    Post-treatment   *P*value
  -------------- --------------- ---------------- ----------
  NO (μmol/l)    58.0 ± 22.9     25.2 ± 19.0      \< 0.01
  TNF-α (μg/l)   4.83 ± 2.6      1.70 ± 1.25      \< 0.01
  IL-2 (ng/l)    6.35 ± 2.13     4.25 ± 1.13      \< 0.01
  IL-6 (pg/ml)   394.9 ± 134.5   108.0 ± 117.3    \< 0.01
  IL-8 (ng/ml)   1.20 ± 0.63     0.52 ± 0.15      \< 0.01
  LBP (μg/ml)    16.2 ± 8.1      8.2 ± 5.1        \< 0.01

Results
=======

The MARS therapy was associated with a significant removal of NO and certain cytokines such as TNF-α, IL-2, IL-6, IL-8, and lipopolysaccharide binding protein (LBP) (see Table [2](#T2){ref-type="table"}), together with a marked reduction of other nonwater-soluble albumin-bound toxins and water-soluble toxins. These were associated with an improvement of the patients\' clinical conditions including hepatic encephalopathy, deranged hemodynamic situation and renal and respiratory function, thus resulting in a marked decrease of teh Sequential Organ Failure Assessment (SOFA) score and improved outcome: 16 patients were able to be discharged from the hospital or bridged to successful liver transplantation. The overall survival of 39 patients was 41%.

Conclusion
==========

We can confirm the positive therapeutic impact and safety to use MARS on various pathogenic MODS patients associated with elevated levels of NO and cytokines.
